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Automatically detecting mentions of pharmaceutical drugs and chemical substances is key 
for the subsequent extraction of relations of chemicals with other biomedical entities such 
as genes, proteins, diseases, adverse reactions or symptoms. The identification of drug men-
tions is also a prior step for complex event types such as drug dosage recognition, duration 
of medical treatments or drug repurposing. Formally, this task is known as named entity rec-
ognition (NER), meaning automatically identifying mentions of predefined entities of inter-
est in running text. In the domain of medical texts, for chemical entity recognition (CER), 
techniques based on hand-crafted rules and graph-based models can provide adequate per-
formance. In the recent years, the field of natural language processing has mainly pivoted to 
deep learning and state-of-the-art results for most tasks involving natural language are 
usually obtained with artificial neural networks. Competitive resources for drug name rec-
ognition in English medical texts are already available and heavily used, while for other lan-
guages such as Spanish these tools, although clearly needed were missing. In this work, we 
adapt an existing neural NER system, NeuroNER, to the particular domain of Spanish clinical 
case texts, and extend the neural network to be able to take into account additional fea-
tures apart from the plain text. NeuroNER can be considered a competitive baseline system 
for Spanish drug and CER promoted by the Spanish national plan for the advancement of 
language technologies (Plan TL). 
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Availability: PharmacoNER Tagger can be accessed at https://github.com/PlanTL-SANIDAD/
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Introduction 
Chemical compounds and drugs represent a key biomedical entity of common interest for 
a range of scientific disciplines, including medicine and clinical research, pharmacology as 
well as basic biomedical research. Due to the growing amount of clinical texts, medical and 
biomedical literature and medicinal chemistry patents, a systematic approach to recognize 
such entities in order to semantically enrich these documents and enable further relation 
extraction task is needed. Text mining and information extraction efforts are gradually be-
ing adopted to empower the transformation of unstructured running texts to more struc-
tured data representations that can be directly consumed by content analytics and infor-
mation retrieval infrastructures [1]. 
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Application note
Semantically labeling drug mentions in medical documents is a 
necessary step to allow a range of downstream text mining applica-
tions, like drug-resistance, drug dosage recognition, duration of 
medical treatments, drug repurposing, detection of medication-re-
lated allergies, drug-drug interactions or disease-drug relations. 
Drug names show some inherent characteristics such as the con-
straints imposed by the International Nonproprietary Names 
(INN) system by exploiting certain suffixes and prefixes to group 
them according to certain attributes. For instance, the suffix ‘-caine’ 
is usually used for local anesthetics. These properties are not only 
useful for healthcare professionals and pharmacologists to memo-
rize drug names, their attributes and fining them in the clinical liter-
ature, they are also constituting valuable attributes for automatically 
labeling them through language technology tools. 
Named entity recognition (NER) [2] is the task of automatically 
extracting and identifying mentions of entities of interest in run-
ning text, typically through their mention offsets or by classifying 
individual tokens whether they belong to entity mentions of not. 
Among many other uses, such as entity-aware machine translation, 
NER can also be used for the automated information extraction 
and anonymization [3] of medical texts. Early techniques involved 
the use of hand-crafted rules. The most successful approach con-
sisted in using Conditional Random Fields (CRFs), a graph-based 
model for modeling sequences that still relied on features defined 
by humans. In the last years, Natural Language Processing (NLP) 
techniques have been improved with the use of word embeddings, 
that is to say, projections of words to vector spaces such that among 
other findings, the distance can be used as a semantic similarity 
measure [4]. Deep learning (e.g., artificial neural networks [ANNs] 
with a high number of hidden layers) has proved to be extremely 
useful in solving NER problems. In this article, we introduce Phar-
macoNER tagger, NER software based on NeuroNER [5] adapted 
to the domain of Spanish medical texts and improved with non-do-
main-specific features. 
The problem 
Medical documents mentioning drugs and chemical compounds 
offer a relevant source of information regarding the patients’ treat-
ment. For instance, doctors and researchers may be interested in 
finding health records of patients treated with a particular kind of 
compound in order to manually analyze them or use them in bio-
medical NLP pipelines. 
Nevertheless, the task of manually detecting these entities would 
be expensive and time-consuming, which prompts for the develop-
ment of NER systems for automating this task. In the context of 
chemical compounds, NER is usually referred to as chemical entity 
recognition (CER). 
Challenges in NER for medical texts and chemical compounds 
NER itself has proven to be a challenging task because of the ambi-
guity and complexity of human languages. In the particular case of 
CER, additional difficulties arise. 
First of all, not all chemical names present distinctive patterns as 
far as name segments or chemical word morphology are concerned. 
CER systems are particularly sensitive with regard to both spelling 
errors and the tokenization strategy of choice since chemical docu-
ments usually exhibit hyphenated text segments or variable use of 
parentheses, brackets, dots, and other punctuation signs. In addi-
tion, chemical documents tend to be loaded with acronyms and ab-
breviations, which are one of the main sources of false positives.  
Another characteristic that makes CER difficult is the fact that 
the detection of mention boundaries is especially cumbersome 
when long chemicals or modifiers are present. A more in-depth de-
scription of difficulties in tagging chemicals can be found at [6]. 
Other approaches 
In the past, most NER systems were rule-based or leveraged graph-
based models such as CRFs, while nowadays the task is usually ap-
proached with deep learning techniques. In the case of CER sys-
tems, we can highlight some relevant works. 
ChemicalTagger [7] parsed the text with a formal grammar and 
domain-specific regular expressions (regex) and used the parse tree 
in combination with the Part-of-Speech (POS) tags obtained with 
an English tagger in order to extract chemical entities. They report-
ed achieving machine-annotator agreements of 88.9% for phrase 
recognition and 91.9% for phrase-type identification. The test cor-
pus was assembled by compiling 50 paragraphs from the experi-
mental sections of polymer synthesis related papers. 
CheNER [8], a tool for the identification of chemical entities and 
their classes in the biomedical literature, is based on a combination 
of CRFs, regex and dictionary matching. An F-Score of about 73% 
was reported, with minor differences depending on the particular 
experiment. For evaluation, two corpora containing 3,500 docu-
ments with approximately 29,500 annotated chemical entities di-
vided into several classes were used. 
On the other hand, MetaMap [8], a tool for recognizing Unified 
Medical Language System (UMLS) concepts in the text, mapped 
entities to UMLS concepts by the means of rules and a parser. 
In CHEMDNER [6], a drug and chemical names extraction 
competition, the top scoring teams obtained F-scores of 87.39% 
and 88.2% depending on the particular task, employing CRFs and 
domain-specific rules. These scores were obtained in the CHEMD-
NER corpus, a dataset with chemical compounds manually anno-
tated by domain experts. 
With regard to drug recognition, a vast survey on approaches and 
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resources was presented in Liu et al.’s study [9], including classical 
machine learning techniques and hybrid approaches. The authors 
suggested using deep learning techniques for drug recognition as 
future work. 
A system for drug name recognition and classification in biomed-
ical texts was introduced in Segura-Bedmar et al.’s study [10]. By 
combining information obtained by the UMLS MetaMap Transfer 
(MMTx) program and nomenclature rules recommended by the 
World Health Organization (WHO) INNs Program, a broader 
coverage than previous approaches based on standalone MMTx 
was achieved. 
For an extensive review of text mining techniques for drugs and 
chemical compounds, readers can refer to Vazquez et al.’s study [11]. 
Nevertheless, the aforementioned works used techniques that 
have some important limitations [1]. Dictionary-based methods 
have problems dealing with name variability since chemical naming 
exhibits high variation. Rule construction, apart from requiring do-
main knowledge and an extensive manual workload, has proven to 
be difficult to scale to new rules and to transfer to slightly different 
domains. On the other hand, statistical models such as CRFs and 
classic machine learning algorithms are not powerful enough for 
detecting some patterns and require a certain amount of feature en-
gineering. All these previous approaches focused on data in English, 
despite the fact that there is a considerable amount of textual data 
and repositories (e.g., MEDES, Scielo, Ibecs, or Cuiden), as well as 
a large medical end users community interested in tools for process-
ing data in Spanish. Regarding other languages, this work [12] pre-
sented a system based on CRFs that was capable of recognizing en-
tities in French biomedical documents.  
Our proposal 
Our proposal involves the adaption of a state-of-the-art NER (i.e., 
NeuroNER) based on deep learning to the particular domain of the 
Spanish medical texts in order to identify identities as proteins or 
other components. Remarkably, the system we base our work on 
has a CRF layer apart from deep learning components. The original 
system takes tokens as its input, while our proposal involves using 
additional features in the neural network. 
Key innovations 
Our contribution consists in extending an existing neural NER sys-
tem with additional features that had worked with classic CERs. In 
particular, POS tags, gazetteer features, and affixes features have been 
added to the network and were as a pre-preprocessing step. Different 
experiments have been conducted in order to determine whether 
these features improved the performance of the neural network. The 
extension of the neural network is domain and language-agnostic, 
while the pre-processing is domain-dependent and specific tools for 
Spanish medical texts have been used. By the neural network itself 
being language-agnostic we mean that our system could be adapted 
to other languages by building gazetteer and affix dictionaries and 
using a POS tagger trained for the required language. 
NeuroNER 
NeuroNER, an open-source program for named-entity recogni-
tion, achieved state-of-the-art performance by having a neural ar-
chitecture containing three layers: (1) character-enhanced to-
ken-embedding layer, (2) a label prediction layer, and (3) a label se-
quence optimization layer. 
Recurrent neural networks (RNNs) are ANNs such that the 
computational graphs have cycles, which are used for dealing with 
sequences [13]. Long short term memory (LSTM) [14] are gated 
units widely used in RNN implementations. A Bidirectional LSTM 
(Bi-LSTM) is an LSTM unit such that two inputs layers with oppo-
site directions are present, which allows the network to get informa-
tion from both the past and future states simultaneously. Neu-
roNER makes use of Bi-LSTM for the character-enhanced to-
ken-embedding layer, while character embeddings are previously 
passed through their own LSTM. 
In Fig. 1, we show a representation of the ANN in the original 
NeuroNER implementation. We must notice that this is just a snip-
pet of the structure of one token. The full ANN has connections for 
the RNN between tokens from the character-enhanced token em-
bedding upwards. For details about this model, readers can refer to 
Dernoncourt et al. [15]. 
In addition, NeuroNER has the ability to load pre-trained token 
embeddings, which may increase final performance and decrease 
training time. For more details about NeuroNER, please refer to 
the following related works: Dernoncourt et al. [5,15]. 
Proposed Method 
The following features have been added to both the neural network 
and the dataset parser of NeuroNER: 
‒ POS features: with our modification, PharmacoNER tagger can 
parse annotations (both in BRAT or CONLL formats) of POS 
tags, encode them with a one-hot encoding for each token and in-
clude this in the token embedding layer of the network. 
‒ Gazetteer features: our modified version of NeuroNER is able to 
parse a text file with terms related to the target entities, build a dic-
tionary and assign a positive value for the words that are found in 
this dictionary. This feature is then concatenated with the charac-
ter-enhanced token embedding layer. A file with the dictionary 
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has to be supplied by the user.  
‒ Affixes features: PharmacoNER tagger can use information re-
garding affixes in a similar manner as the gazetteer features, but 
using regular expressions to detect whether a particular word has 
an affix related to the target entities. A file of affixes shall be sup-
plied by the user. 
Notice that the aforementioned features are domain and lan-
guage independent. The final software can be found in Github 
(https://github.com/PlanTL-SANIDAD/PharmacoNER), with 
information about installation and samples. In Fig. 2, the adaptation 
of the neural network is also depicted, showing the differences from 
Fig. 1. 
Evaluation 
Data 
For evaluating PharmacoNER tagger, we used the SPACCC data-
set, a manually annotated corpus of 1,000 clinical cases written in 
Spanish and annotated with mentions of chemical compounds, 
drugs, genes, and proteins. In particular, the set of labels consists of 
Normalizables (4,398 labels), No Normalizables (50 labels), Pro-
teins (3,009 labels), and Unclear (167 labels). Note that Normaliz-
ables and No Normalizables refer to chemical entities. For instance, 
the word “triglicéridos” (triglycerides) is annotated as Normaliz-
able, while “receptores de progesterona” (progesterone receptors) 
Fig. 1. Schematic representation of the artificial neural networks 
for a single token in NeuroNER: Snippet of the architecture used 
in NeuroNER. The type of recurrent neural network (RNN) is long 
short term memory (LSTM). n is the number of tokens Xi is the i
th 
token. Vr is the mapping from tokens to token embeddings. l(i) 
is the number of characters, and Xi,j is the j
th character of the i th 
token. Vc is the mapping from characters to character embeddings. 
ei is the character-enhanced token embeddings of the i th token. 
di is the output of the LSTM of label prediction layer, ai is the 
probability vector over labels, and yi is the predicted label of the 
i th token. Adapted from Dernoncourt et al. J Am Med Inform Assoc 
2017;24:596-606 [15].
Fig. 2. Schematic representation of the the artificial neural 
networks for a single token in PharmacoNER tagger: Snippet of 
the architecture used in PharmacoNER tagger. All notations are 
the same as in Fig. 1. We added the following features in the 
character-enhanced token embeddings: Vp is the mapping from 
the specific token to its Part-of-Speech, Va is boolean mapping 
to identify if the given token contains any of the affixes in the 
database, and Vg is a boolean mapping to the gazetteer database. 
RNN, recurrent neural network.
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is labelled as Proteins. One can notice that the dataset is heavily im-
balanced. The dataset has not been released yet due to an ongoing 
shared task (http://temu.bsc.es/pharmaconer). 
Embeddings 
Eight different pre-trained word embeddings have been tested, 
from the Spanish Billion Word Corpus (SBWC) and data crawled 
from SciELO (http://www.scielo.org) and health-related catego-
ries of Wikipedia. SBWC data is general-domain, while SciELO 
and Wikipedia are in-domain. 
‒ General domain (Universidad de Chile Spanish Word Embed-
dings, https://github.com/uchile-nlp/spanish-word-embed-
dings): 
FastText embeddings from SBWC 
GloVe embeddings from SBWC 
- Domain-specific (PlanTL Embeddings, https://github.com/
PlanTL-SANIDAD/Embeddings): 
FastText Scielo 
FastText medical Wikipedia 
FastText Scielo + Health Wikipedia 
Word2Vec Scielo 
Word2Vec medical Wikipedia 
Word2Vec Scielo + Health Wikipedia 
Sampling 
The SPACCC dataset was split with the following proportions: 
80% for training, 10% for validation, and 10% for test. 
Since the dataset is imbalanced, a stratified splitting has been ap-
plied, in order to approximately maintain the same proportions of 
labels in the three sets.  
SPACCC POS tagger and freeling 
FreeLing [16] is an open source language analysis tool suite, re-
leased under the Affero GNU General Public License of the Free 
Software Foundation. FreeLing was used for building the SPACCC 
POS Tagger (https://github.com/PlanTL-SANIDAD), which is a 
POS tagger trained with Spanish medical texts. SPACCC POS Tag-
ger was successfully applied to the provided data as a pre-processing 
step. 
Gazetteer 
The gazetteer dictionary was built with a pharmaceutical “nomen-
clator” maintained by the Spanish government (https://www.
mscbs.gob.es/profesionales/nomenclator.do), which consists of 
drug names and active components of medicines. For instance, in-
domethacin is listed as an active ingredient, and therefore the ap-
pearances of this particular word are marked as belonging to the 
dictionary. 
List of affixes 
The list of affixes was retrieved from a biomedical website (http://
blog.nclexmastery.com/drug-stems-prefixes-roots-suffixes/) and 
translated into Spanish. The final format is a tab-separated file, with 
the type of affix (e.g., suffix, prefix, or root), the affix in English, the 
affix in Spanish, an example in English and the Drug class. For 
PharmacoNER tagger, only the columns type, and affix in Spanish 
are used. 
Metrics 
The CONLL evaluation script is used for evaluating the results. 
The following overall metrics are computed: accuracy, precision, 
recall, F1 score. For details about the metrics, please refer to Kral-
linger et al.’s study [1]. For the sake of comparison, we will utilize 
the F1 score as the primary performance metric. 
Results with the best configuration 
To train our system, we tested several configurations with various 
levels, which are now described: 
‒ Pre-trained embeddings: Total of eight models, from general do-
main and in-domain. 
‒ POS: Yes (using POS) and No (without POS information) 
‒ Gazetteer: Yes (with gazetteer) and No (without gazetteer) 
‒ Affixes: Yes (with affix information) and No (without affix infor-
mation). 
We trained our systems until convergence, that is until no im-
provement was identified in the development set for at least 10 ep-
ochs. In addition, given that the number of samples from the classes 
No Normalizables and Unclear are too small, we decided to discard 
those classes. This led our NER system to have the goal of identify-
ing Proteins and Normalizable chemicals. First of all, to narrow 
down the search space, we turned off all additional features and just 
tested the word embeddings. Once the best embedding was found, 
we fixed it and tested the other configurations. 
In Table 1, we present the result of our system regarding the met-
rics mentioned in Section 4.7. The final setting is: POS with Gazet-
teer turned one. One can notice that there is not a great difference 
between the validation and the test set in all metrics, thus meaning 
that no overfitting occurred.  
Conclusion 
In this article we have introduced PharmacoNER tagger, a neural 
NER based on an existing state-of-the-art system, NeuroNER. We 
extended and especially adapted to the particular domain of chemi-
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cal compounds in Spanish medical texts. The results in the valida-
tion set of the experiments with the SPACCC dataset have showed 
that the best configuration consisted of the FastText Scielo + Health 
Wikipedia embeddings, the POS, and the gazetteer, which have prov-
en to be an additional source of information that can be leveraged by 
neural networks. In the test set, the aforementioned best configura-
tion obtained an F1 score of 89.06. The extension to the network is 
domain-agnostic and could be used in other fields, but the pre-pro-
cessing steps have been specifically designed for our domain. 
CER involves additional challenges to the ones already present in 
generic NER. Our work shows that some of the sources of addi-
tional information typically used in previous CER systems based 
on non-neural techniques, such as affixes, can be leveraged as well 
by state-of-the-art neural NER systems. 
We foresee that this resource will be a valuable contribution not 
only to semantically enhance medical texts in Spanish for pharma-
cological and drug-related information, but it also highlights a use-
ful approach on how to implement medical NER taggers for lan-
guages other than English. Moreover, PharmacoNER tagger will be 
a useful competitive baseline system and design principle for the 
upcoming PharmacoNER BioNLP 2019 shared task. 
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